SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Bishop who wrote (18655)1/2/2000 11:20:00 AM
From: elcasmirb  Read Replies (1) of 150070
 
Could be a Canadian one to watch....





LOR Lorus Therapeutics Inc.
Last Trade 12/31 12:59


Last
Change
% Change
Hi
Low
Open
Vol
1.2100
+.1800
+17.48
1.2500
1.0500
1.1000
1391200


Profile
Lorus Therapeutics Inc. is a pharmaceutical
company focused on the development of
cancer therapies. The Company has products
in clinical trials for the treatment of pancreatic
cancer.

Exchange: Toronto
Company Graph

Other graphs
3 Months 6 Months 1 Year


NEWS
12/20 16:17 Lorus Therapeutics
Reports Results of International
Scientific

12/16 7:19 Lorus Therapeutics
Completes Early Exercise Of
Warrants For

12/15 17:25 Lorus Therapeutics
Completes Early Exercise Of
Warrants For

12/7 10:21 Canadian Equity
Movers: Gold Stocks, Dylex, Lorus
Therapeutics

12/7 7:15 Lorus Therapeutics
Announces FDA Approval To Begin
Clinical

11/29 7:32 Lorus Therapeutics
Announces Anti-Cancer Drug GTI
2501

11/22 8:10 Lorus Therapeutics
Announces Dramatic Anti-Tumor
Results For

11/16 7:18 Lorus Therapeutics
Files IND Application Following
Positive

11/1 7:23 LORUS
THERAPEUTICS COMPLETES
ACQUISITION OF GENESENSE

10/30 0:17 LORUS
THERAPEUTICS REPORTS YEAR
END RESULTS



KEY DATA

Historical/risk data
Current Price
1.2100
52 Week Hi
12/08/1999
1.4400
52 Week Low
03/17/1999
0.2600
1 Year Return
212.12

Per share data
Shares (Million)
42.75
Earnings
-0.10
Sales
0.00
Dividend
0.00

Ratio/yield
* Market
Capitalization
44.03
Price / Earnings
neg
Dividend Yield
0.00

* based on closing price
of previous day



Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News